Purohit D P, Perl D P, Haroutunian V, Powchik P, Davidson M, Davis K L
Department of Pathology, Mount Sinai Medical Center, New York, NY 10029-6574, USA.
Arch Gen Psychiatry. 1998 Mar;55(3):205-11. doi: 10.1001/archpsyc.55.3.205.
Clinical studies suggest that severe cognitive impairment is common among elderly patients with schizophrenia who reside in long-stay psychiatric institutions; however, previous autopsy-based neuropathologic investigations have provided conflicting results about the occurrence of Alzheimer disease (AD) in elderly patients with schizophrenia. We report the results of a comprehensive neuropathologic study performed to identify AD and other dementing neurodegenerative diseases in elderly patients with schizophrenia.
A neuropathologic examination was performed on 100 consecutive autopsy brain specimens of patients aged 52 to 101 years (mean, 76.5 years). A cognitive assessment of these cases was also done by employing the Clinical Dementia Rating Scale. For comparison, we included 47 patients with nonschizophrenic psychiatric disorders from the same psychiatric hospital and 50 age-matched control subjects.
Although 72% of the patients with schizophrenia showed cognitive impairment, AD was diagnosed in only 9% of the patients and other dementing diseases were diagnosed in only 4% of the patients. The degree of senile plaques or neurofibrillary tangles was not different in the group with schizophrenia compared with the age-matched controls or the group with nonschizophrenic psychiatric disorders. The higher Clinical Dementia Rating Scale scores lacked correlation with neuropathologic evidence of dementing disorders. In the 87 cases lacking a neuropathologic diagnosis of AD or other dementing disorders, the mean (+/-SD) Clinical Dementia Rating Scale score was 2.21 (+/-1.14), with 43 of the cases scoring 3 or higher (indicating severe, profound, or terminal cognitive impairment).
This study provides evidence that elderly patients with schizophrenia are not inordinately prone to the development of AD or to increased senile plaques or neurofibrillary tangle formation in the brain. Other dementing neurodegenerative disorders are also uncommon. The cognitive impairment in elderly patients with schizophrenia must, therefore, be related to some alternative mechanisms.
临床研究表明,居住在长期精神病院的老年精神分裂症患者中严重认知障碍很常见;然而,以往基于尸检的神经病理学研究对于老年精神分裂症患者中阿尔茨海默病(AD)的发生情况给出了相互矛盾的结果。我们报告了一项全面的神经病理学研究结果,该研究旨在识别老年精神分裂症患者中的AD及其他导致痴呆的神经退行性疾病。
对100例年龄在52至101岁(平均76.5岁)的连续尸检脑标本进行了神经病理学检查。还采用临床痴呆评定量表对这些病例进行了认知评估。为作比较,我们纳入了来自同一精神病院的47例非精神分裂症性精神障碍患者以及50例年龄匹配的对照者。
尽管72%的精神分裂症患者存在认知障碍,但仅9%的患者被诊断为AD,仅4%的患者被诊断为其他导致痴呆的疾病。与年龄匹配的对照组或非精神分裂症性精神障碍组相比,精神分裂症组的老年斑或神经原纤维缠结程度并无差异。较高的临床痴呆评定量表评分与痴呆性疾病的神经病理学证据缺乏相关性。在87例未通过神经病理学诊断为AD或其他痴呆性疾病的病例中,临床痴呆评定量表评分的平均值(±标准差)为2.21(±1.14),其中43例评分达到3分或更高(表明存在严重、极重度或终末期认知障碍)。
本研究提供的证据表明,老年精神分裂症患者并非特别容易患AD,也不会过度增加大脑中老年斑或神经原纤维缠结的形成。其他导致痴呆的神经退行性疾病也不常见。因此,老年精神分裂症患者的认知障碍必定与某些其他机制有关。